TrialThe oncologist2024

Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.

Ryan D Gentzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.